![7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine in PDB entry 7jlr, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/7jlr_entity_2_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>7jlr</span> contains 2 copies of <span class='highlight'>7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine</span>. Side view.")
![7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine in PDB entry 7jlr, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/7jlr_entity_2_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>7jlr</span> contains 2 copies of <span class='highlight'>7-(azepan-1-yl)-5-ethyl-3-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine</span>. Top view.")
Environment details NEW
V0D 301 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.